AVI BioPharma, Inc. · Bothell, WA United States (NASDAQ: AVII)
Key AVI BioPharma, Inc. Financials
| Company Type | Public -(NASDAQ: AVII) Headquarters |
|---|---|
| Fiscal Year-End | December |
| Sales (mil.) | $0.1 |
| 2010 Employees | 98 |
AVI BioPharma, Inc. Income Statement
| Dec 99 | Dec 95 | Dec 94 | |
| Revenue | 0.1 | 0.1 | 0.0 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | 0.1 | 0.1 | 0.0 |
| Gross Profit Margin | -- | -- | -- |
| SG&A Expense | 1.7 | -- | -- |
| Depreciation & Amortization | 0.3 | -- | -- |
| Operating Income | (8.3) | -- | -- |
| Operating Margin | -8300% | --% | --% |
| Nonoperating Income | (0.1) | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (8.3) | -- | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (8.3) | -- | -- |
| Total Net Income | (8.3) | (2.6) | (2.2) |
| Net Profit Margin | -8300% | -3117.1% | --% |
| Diluted EPS from Total Net Income | (0.62) | -- | -- |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
AVI BioPharma, Inc. Balance Sheet
| Assets | Dec 99 | Dec 95 | Dec 94 |
| Current Assets | |||
| Cash | 8.7 | -- | -- |
| Net Receivables | -- | -- | -- |
| Inventories | -- | -- | -- |
| Other Current Assets | 3.0 | -- | -- |
| Total Current Assets | 11.7 | -- | -- |
| Net Fixed Assets | 0.4 | -- | -- |
| Other Noncurrent Assets | 0.8 | -- | -- |
| Total Assets | 12.9 | -- | -- |
| Liabilities | Dec 99 | Dec 95 | Dec 94 |
| Current Liabilities | |||
| Accounts Payable | 0.7 | -- | -- |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 0.3 | -- | -- |
| Total Current Liabilities | 1.0 | -- | -- |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 0.0 | -- | -- |
| Total Liabilities | 1.0 | -- | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 11.9 | -- | -- |
| Total Equity | 11.9 | -- | -- |
| Shares Outstanding (thou.) | 110,435.3 | -- | -- |
All amounts in millions of US Dollars except per share amounts.
AVI BioPharma, Inc. Cash Flow Statement
| Dec 99 | Dec 95 | Dec 94 | |
| Net Operating Cash Flow | (8) | -- | -- |
| Net Investing Cash Flow | (0.5) | -- | -- |
| Net Financing Cash Flow | 8.2 | ||
| Net Change in Cash | 0.2 | ||
| Depreciation & Amortization | 0.3 | ||
| Capital Expenditures | (0.2) | ||
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.